DOCUMENT
updated infographic.pdf (5.9 MB)
VIDEO
derm23191videoabstract.mp4 (519.91 MB)
1/0
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6 to 11 Years of Age with Severe Atopic Dermatitis
media
posted on 2023-09-12, 07:53 authored by Adis journals on behalf of, Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah Alexander LevitThe above infographic and video abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
